AIMC Topic: Drug Discovery

Clear Filters Showing 81 to 90 of 1689 articles

Harnessing AI for precision medicine and its applications in genomics, systems pharmacology, and drug discovery.

European journal of pharmacology
Artificial intelligence and machine learning are revolutionizing pharmaceutical research by enabling the rapid analysis of complex datasets and automating critical tasks throughout the drug-development process. In this review, we surveyed how artific...

Discovery of Novel 4,5-Dihydropyrrolo[3,4-]pyrazol-6()-one-Based Tubulin Inhibitors Targeting Colchicine Binding Site with Potent Anti-Ovarian Cancer Activity.

Journal of medicinal chemistry
To address the toxicity of current microtubule inhibitors, we employed the GeminiMol deep learning model to screen the Zinc20 database, identifying a novel 4,5-dihydropyrrolo[3,4-]pyrazol-6(2)-one scaffold () targeting the colchicine binding site. Su...

Cross-Modal Interaction-Aware Progressive Fusion Network for Drug-Target Interaction Prediction.

Journal of chemical information and modeling
Drug-target interaction (DTI) prediction plays a pivotal role in drug discovery. In recent years, deep learning-based models have been advanced rapidly, accelerating the identification of potential DTIs. However, how to effectively capture the cross-...

Drug and Clinical Candidate Drug Data in ChEMBL.

Journal of medicinal chemistry
ChEMBL is a large-scale, open-access, FAIR database of bioactive molecules with drug-like properties. ChEMBL 35 contains 17,500 approved drugs, and drugs that are progressing through the clinical development pipeline. Drug curation has formed an inte...

PyaiVS unifies AI workflows to accelerate ligand discovery and yields ABCG2 inhibitors.

European journal of medicinal chemistry
Developing optimized AI models for virtual screening requires coordinated selection of algorithms, molecular representations, and data splitting strategies, yet lacks integrated tools. We present PyaiVS, a Python package that integrates nine machine ...

Graph Neural Networks in Modern AI-Aided Drug Discovery.

Chemical reviews
Graph neural networks (GNNs), as topology/structure-aware models within deep learning, have emerged as powerful tools for AI-aided drug discovery (AIDD). By directly operating on molecular graphs, GNNs offer an intuitive and expressive framework for ...

Integrating Machine Learning into Free Energy Perturbation Workflows.

Journal of chemical information and modeling
Free energy perturbation (FEP) methods are among the most accurate tools in structure-based drug design for predicting protein-ligand binding affinities. However, their adoption remains limited due to high computational demands and complex setup proc...

Deep Learning-Driven Discovery of Novel Antimicrobial Peptides from Large-Scale Protist Genomes and Experimental Characterization.

Journal of chemical information and modeling
The escalating issue of antibiotic resistance has created an urgent global demand within the biomedical field for the discovery of novel antimicrobial molecules as alternatives to traditional antibiotics. Previous studies have reported the identifica...

Bioactivity Deep Learning for Complex Structure-Free Compound-Protein Interaction Prediction.

Journal of chemical information and modeling
Protein-ligand binding affinity assessment plays a pivotal role in virtual drug screening, yet conventional data-driven approaches rely heavily on limited protein-ligand crystal structures. Structure-free compound-protein interaction (CPI) methods ha...

Development and Validation of an Automated DNA-Encoded Library Screening Data Analysis Platform: PB-DEL Autoscreening Analysis (PB-DELASA).

Journal of chemical information and modeling
Tools available for analyzing next-generation sequencing (NGS) data produced from DNA-encoded library (DEL) screening campaigns are often constrained to customized methods developed internally by individual institutes, which usually generate data spe...